| Product Code: ETC9626869 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Patented Drugs Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Patented Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Patented Drugs Market - Industry Life Cycle |
3.4 Taiwan Patented Drugs Market - Porter's Five Forces |
3.5 Taiwan Patented Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.6 Taiwan Patented Drugs Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.7 Taiwan Patented Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Taiwan Patented Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for innovative and effective pharmaceutical products |
4.2.2 Strong government support and initiatives to promote research and development in the healthcare sector |
4.2.3 Growing healthcare expenditure and rising prevalence of chronic diseases in Taiwan |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for patent approval and drug registration |
4.3.2 High competition from generic drug manufacturers impacting the market share of patented drugs |
4.3.3 Potential pricing pressures and reimbursement challenges in the healthcare system |
5 Taiwan Patented Drugs Market Trends |
6 Taiwan Patented Drugs Market, By Types |
6.1 Taiwan Patented Drugs Market, By Distribution Channel |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Patented Drugs Market Revenues & Volume, By Distribution Channel, 2021- 2031F |
6.1.3 Taiwan Patented Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.1.4 Taiwan Patented Drugs Market Revenues & Volume, By Drug Store and Retail Pharmacies, 2021- 2031F |
6.1.5 Taiwan Patented Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.2 Taiwan Patented Drugs Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Patented Drugs Market Revenues & Volume, By Solid Drug Product, 2021- 2031F |
6.2.3 Taiwan Patented Drugs Market Revenues & Volume, By Liquid Drug Product, 2021- 2031F |
6.2.4 Taiwan Patented Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Taiwan Patented Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Patented Drugs Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.3.3 Taiwan Patented Drugs Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.4 Taiwan Patented Drugs Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.3.5 Taiwan Patented Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Taiwan Patented Drugs Market Import-Export Trade Statistics |
7.1 Taiwan Patented Drugs Market Export to Major Countries |
7.2 Taiwan Patented Drugs Market Imports from Major Countries |
8 Taiwan Patented Drugs Market Key Performance Indicators |
8.1 Research and development investment in patented drug development |
8.2 Number of new patents granted for pharmaceutical innovations |
8.3 Adoption rate of patented drugs in healthcare facilities |
8.4 Rate of successful commercialization of patented drug research projects |
8.5 Number of collaborations between pharmaceutical companies and research institutions in Taiwan |
9 Taiwan Patented Drugs Market - Opportunity Assessment |
9.1 Taiwan Patented Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.2 Taiwan Patented Drugs Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.3 Taiwan Patented Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Taiwan Patented Drugs Market - Competitive Landscape |
10.1 Taiwan Patented Drugs Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Patented Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here